Literature DB >> 9804339

Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality.

E Zettersten1, M Q Man, J Sato, M Denda, A Farrell, R Ghadially, M L Williams, K R Feingold, P M Elias.   

Abstract

Cholesterol sulfate is a multifunctional sterol metabolite, produced in large amounts in squamous keratinizing epithelia. Because patients with recessive x-linked ichthyosis display not only a 10-fold increase in cholesterol sulfate, but also a 50% reduction in cholesterol, we assessed here whether cholesterol sulfate accumulation and/or cholesterol deficiency produce abnormal barrier function in recessive x-linked ichthyosis. Patients with recessive x-linked ichthyosis display both an abnormal barrier under basal conditions, and a delay in barrier recovery after acute perturbation, which correlate with minor abnormalities in membrane structure and extensive lamellar-phase separation. Moreover, both the functional and the structural abnormalities were corrected by topical cholesterol. Yet, topical cholesterol sulfate produced both a barrier abnormality in intact skin and extracellular abnormalities in isolated stratum corneum, effects largely reversed by coapplications of cholesterol. Together, these results suggest that cholesterol sulfate accumulation rather than cholesterol deficiency is responsible for the barrier abnormality. Despite the apparent importance of cholesterol sulfate-to-cholesterol processing for normal barrier homeostasis, neither steroid sulfatase activity nor mRNA levels are upregulated following acute perturbations. These results demonstrate both a potential role for cholesterol sulfate-to-cholesterol processing in normal permeability barrier homeostasis, and that basal levels of steroid sulfatase are sufficient to accommodate acute insults to the permeability barrier.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804339     DOI: 10.1046/j.1523-1747.1998.00386.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Long and very long lamellar phases in model stratum corneum lipid membranes.

Authors:  Petra Pullmannová; Elena Ermakova; Andrej Kováčik; Lukáš Opálka; Jaroslav Maixner; Jarmila Zbytovská; Norbert Kučerka; Kateřina Vávrová
Journal:  J Lipid Res       Date:  2019-03-18       Impact factor: 5.922

2.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

3.  Cholesterol sulfate and Ca(2+) modulate the mixing properties of lipids in stratum corneum model mixtures.

Authors:  Marjolaine Arseneault; Michel Lafleur
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

4.  Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Authors:  Peter M Elias; Mary L Williams; Kenneth R Feingold
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

Review 5.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

6.  Investigation of stratum corneum lipid model membranes with free fatty acid composition by neutron diffraction.

Authors:  Natalia Yu Ryabova; M A Kiselev; S Dante; T Hauss; A M Balagurov
Journal:  Eur Biophys J       Date:  2009-12-15       Impact factor: 1.733

Review 7.  Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis.

Authors:  Peter M Elias; Mary L Williams; Eung-Ho Choi; Kenneth R Feingold
Journal:  Biochim Biophys Acta       Date:  2013-11-27

Review 8.  Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism.

Authors:  Peter M Elias; Mary L Williams; Walter M Holleran; Yan J Jiang; Matthias Schmuth
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

9.  Pathogenesis of the cutaneous phenotype in inherited disorders of cholesterol metabolism: Therapeutic implications for topical treatment of these disorders.

Authors:  Peter M Elias; Debra Crumrine; Amy Paller; Marina Rodriguez-Martin; Mary L Williams
Journal:  Dermatoendocrinol       Date:  2011-04-01

10.  PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin.

Authors:  Simona Frateschi; Eric Camerer; Giovanna Crisante; Sarah Rieser; Mathieu Membrez; Roch-Philippe Charles; Friedrich Beermann; Jean-Christophe Stehle; Bernadette Breiden; Konrad Sandhoff; Samuel Rotman; Marek Haftek; Anne Wilson; Stephan Ryser; Martin Steinhoff; Shaun R Coughlin; Edith Hummler
Journal:  Nat Commun       Date:  2011-01-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.